Efficacy of neonatal vitamin A supplementation in improving child survival in Haryana, India: generation of evidence necessary for informing global policy
Not Applicable
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 45000
Inclusion Criteria
Age from 2 hours to 72 hours; Consent to participate; All births in the study area that are contacted by enrolment team within the eligible age window
Exclusion Criteria
Unable to feed on offering feeds, as reported by the mother; Mother does not intend to stay in the study area for at least 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Risk of deathTimepoint: Between receiving the intervention or placebo and 6 months of age.
- Secondary Outcome Measures
Name Time Method Bulging fontanelle, vomiting, irritability, fever, diarrhea, inability to suck or feed, convulsions or any other conditions that caused parent to be concernedTimepoint: Between receiving the intervention/placebo and 3 days of age;Hospital admissionTimepoint: Between receiving the intervention/placebo and 6 months of age;Risk of deathTimepoint: Between receiving the intervention/placebo and 28 days of age;Risk of deathTimepoint: Period between receiving the intervention/placebo and 12 months of age;Vitamin A status (RBP, SR, C Reactive protein) in a subgroup of infants and mothers in the intervention and placebo groupsTimepoint: At 2 weeks and 3 months of age in infants; at 3 months of age in mothers